-
Non-stochastic reassembly of a metabolically cohesive gut consortium shaped by N-acetyl-lactosamine-enriched fibers. Gut Microbes (IF 12.2) Pub Date : 2024-12-18 Madison Moore,Hunter D Whittington,Rebecca Knickmeyer,M Andrea Azcarate-Peril,Jose M Bruno-Bárcena
Diet is one of the main factors shaping the human microbiome, yet our understanding of how specific dietary components influence microbial consortia assembly and subsequent stability in response to press disturbances - such as increasing resource availability (feeding rate) - is still incomplete. This study explores the reproducible re-assembly, metabolic interplay, and compositional stability within
-
The regulatory effect of chitooligosaccharides on islet inflammation in T2D individuals after islet cell transplantation: the mechanism behind Candida albicans abundance and macrophage polarization. Gut Microbes (IF 12.2) Pub Date : 2024-12-18 Yayu Zhang,Xiaoguo Ji,Kunlin Chang,Hao Yin,Mengyao Zhao,Liming Zhao
Islet cell transplantation (ICT) represents a promising therapeutic approach for addressing diabetes mellitus. However, the islet inflammation during transplantation significantly reduces the surgical outcome rate, which is related to the polarization of macrophages. Chitooligosaccharides (COS) was previously reported which could modulate the immune system, alleviate inflammation, regulate gut microecology
-
Gut microbiota and microbial metabolites for osteoporosis. Gut Microbes (IF 12.2) Pub Date : 2024-12-17 Xuan-Qi Zheng,Ding-Ben Wang,Yi-Rong Jiang,Chun-Li Song
Osteoporosis is an age-related bone metabolic disease. As an essential endocrine organ, the skeletal system is intricately connected with extraosseous organs. The crosstalk between bones and other organs supports this view. In recent years, the link between the gut microecology and bone metabolism has become an important research topic, both in preclinical studies and in clinical trials. Many studies
-
Genomic island-encoded LmiA regulates acid resistance and biofilm formation in enterohemorrhagic Escherichia coli O157:H7. Gut Microbes (IF 12.2) Pub Date : 2024-12-17 Hongmin Sun,Lingyan Jiang,Jingnan Chen,Chenbo Kang,Jun Yan,Shuai Ma,Mengjie Zhao,Houliang Guo,Bin Yang
Enterohemorrhagic Escherichia coli (EHEC) O157:H7 is an important intestinal pathogen that causes severe foodborne diseases. We previously demonstrated that the genomic island-encoded regulator LmiA activates the locus of enterocyte effacement (LEE) genes to promote EHEC O157:H7 adherence and colonization in the host intestine. However, whether LmiA is involved in the regulation of any other biological
-
Abnormalities in gut virome signatures linked with cognitive impairment in older adults. Gut Microbes (IF 12.2) Pub Date : 2024-12-16 Adewale S James,Noorul A Adil,Dayna Goltz,Divyani Tangudu,Diptaraj S Chaudhari,Rohit Shukla,Vivek Kumar,Ambuj Kumar,Michal M Masternak,Peter Holland,Corinne Labyak,Adam Golden,Mariana Dangiolo,Andrea Y Arikawa,Judyta Kociolek,Amoy Fraser,Cynthia Williams,Marc Agronin,Mariolga Aymat,Shalini Jain,Hariom Yadav
Multiple emerging lines of evidence indicate that the microbiome contributes to aging and cognitive health. However, the roles of distinct microbial components, such as viruses (virome) and their interactions with bacteria (bacteriome), as well as their metabolic pathways (metabolome) in relation to aging and cognitive function, remain poorly understood. Here, we present proof-of-concept results from
-
The mycobiome as integral part of the gut microbiome: crucial role of symbiotic fungi in health and disease. Gut Microbes (IF 12.2) Pub Date : 2024-12-15 Hui Huang,Qiurong Wang,Ying Yang,Wei Zhong,Feng He,Jun Li
The gut mycobiome significantly affects host health and immunity. However, most studies have focused on symbiotic bacteria in the gut microbiome, whereas less attention has been given to symbiotic fungi. Although fungi constitute only 0.01%-0.1% of the gut microbiome, their larger size and unique immunoregulatory functions make them significant. Factors like diet, antimicrobials use, and age can disrupt
-
The microbiota metabolite, phloroglucinol, confers long-term protection against inflammation. Gut Microbes (IF 12.2) Pub Date : 2024-12-15 Janire Castelo,Sarai Araujo-Aris,Diego Barriales,Samuel Tanner Pasco,Iratxe Seoane,Ainize Peña-Cearra,Ainhoa Palacios,Carolina Simó,Virginia Garcia-Cañas,Muthita Khamwong,Itziar Martín-Ruiz,Monika Gonzalez-Lopez,Laura Barcena,José Ezequiel Martín Rodríguez,José Luís Lavín,Naiara Gutiez,Raquel Marcos,Estibaliz Atondo,Arantza Cobela,Laura Plaza-Vinuesa,Adrián Plata,Eneko Santos-Fernandez,Alberto Fernandez-Tejada
Phloroglucinol is a key byproduct of gut microbial metabolism that has been widely used as a treatment for irritable bowel syndrome. Here, we demonstrate that phloroglucinol tempers macrophage responses to pro-inflammatory pathogens and stimuli. In vivo, phloroglucinol administration decreases gut and extraintestinal inflammation in murine models of inflammatory bowel disease and systemic infection
-
Hypusination in intestinal epithelial cells protects mice from infectious colitis. Gut Microbes (IF 12.2) Pub Date : 2024-12-14 Alain P Gobert,Caroline V Hawkins,Kamery J Williams,Lydia A Snyder,Daniel P Barry,Mohammad Asim,Margaret M Allaman,Kara M McNamara,Alberto G Delgado,Yu Wang,Shilin Zhao,Kristie L Rose,M Blanca Piazuelo,Keith T Wilson
Enteropathogenic Escherichia coli (EPEC) is a bacterium that causes attaching/effacing (A/E) lesions and serious diarrheal disease, a major health issue in developing countries. EPEC pathogenicity results from the effect of virulence factors and dysregulation of host responses. Polyamines, including spermidine, play a major role in intestinal homeostasis. Spermidine is the substrate for deoxyhypusine
-
Dietary modulation of gut microbiota affects susceptibility to drug-induced liver injury. Gut Microbes (IF 12.2) Pub Date : 2024-12-14 Han Pan,Delei Song,Zhiyi Wang,Xin Yang,Pei Luo,Wei Li,Yan Li,Mengxue Gong,Chenhong Zhang
The rising incidence of drug-induced liver injury (DILI) parallels contemporary dietary shifts that have transformed the composition of human gut microbiota. The relationship between these phenomena remains unknown. Here, it is unveiled that a high fiber diet (HFiD) provides substantial protection against DILI, whereas a western style diet (WSD) significantly exacerbates DILI. Gut microbiota transplantation
-
Unexpected vulnerability of Enterococcus faecium to polymyxin B under anaerobic condition. Gut Microbes (IF 12.2) Pub Date : 2024-12-11 Yongjun Son,Bitnara Kim,Pureun Kim,Jihyeon Min,Yerim Park,Jihye Yang,Wonjae Kim,Masanori Toyofuku,Woojun Park
Gram-positive Enterococcus faecium exhibited higher susceptibility (>4-fold) to polymyxin B (PMB), the canonical antimicrobial peptide against Gram-negative bacteria, under anaerobic condition than aerobic condition. Anaerobically grown E. faecium exhibited high vulnerability to PMB, leading to alteration of cell surface and morphology, as observed based on their high dansyl-PMB affinity (>2.9-fold)
-
Role of gut microbes in acute lung injury/acute respiratory distress syndrome. Gut Microbes (IF 12.2) Pub Date : 2024-12-10 Zixuan Ren,Zhihuan Zheng,Xiujing Feng
Acute lung injury (ALI) is an acute, diffuse inflammatory lung condition triggered by factors of severe infections, trauma, shock, burns, ischemia-reperfusion, and mechanical ventilation. It is primarily characterized by refractory hypoxemia and respiratory distress. The more severe form, acute respiratory distress syndrome (ARDS), can progress to multi-organ failure and has a high mortality rate.
-
Alterations of gut virome with close interaction in the progression of estrogen deficiency-induced osteoporosis. Gut Microbes (IF 12.2) Pub Date : 2024-12-09 Yueqi Chen,Chuan Yang,Zihan Deng,Tingwen Xiang,Jiulin Tan,Jianzhong Xu,Dong Sun,Fei Luo
Previous research has established a link between gut microbiota and osteoporosis (OP) advancement. However, there remains a limited understanding of the crucial contribution of the gut virome in the onset and progression of OP. We employed metagenomic shotgun sequencing and gut virome sequencing to process the ovariectomy (OVX)-induced OP murine model, which revealed significant disparities in bacteriome
-
Dietary inulin ameliorates obesity-induced severe acute pancreatitis via gut-pancreas axis. Gut Microbes (IF 12.2) Pub Date : 2024-12-09 Xin Li,Pan Zheng,Yaoyu Zou,Langyi Guan,Nianshuang Li,Jianping Liu,Nonghua Lu,Yin Zhu,Cong He
Obesity is a definitive factor of severity and mortality of acute pancreatitis (AP), and gut microbiota dysbiosis is involved in its pathogenesis. However, the effect of gut microbiota modulation by dietary components on high fat diet (HFD)-induced severe AP remains unclear. Here, we found that the inulin, a soluble dietary fiber, mitigated pancreatic injury and systematic inflammation in mice fed
-
Infant feces-derived Lactobacillus gasseri FWJL-4 mitigates experimental necrotizing enterocolitis via acetate production. Gut Microbes (IF 12.2) Pub Date : 2024-12-08 Li-Long Pan,Yudong Sun,Xiaoliang Dong,Zhengnan Ren,Binbin Li,Ping Yang,Le Zhang,Jia Sun
Necrotizing enterocolitis (NEC) is a life-threatening disease in premature infants, characterized by high mortality. Recent studies increasingly highlight the role of gut dysbiosis in NEC pathogenesis. Although probiotics have shown some efficacy in preventing NEC, further research is needed to determine potential strains and approaches. In this study, we demonstrated that the novel probiotic strain
-
Gut microbiota CLA and IL-35 induction in macrophages through Gαq/11-mediated STAT1/4 pathway: an animal-based study. Gut Microbes (IF 12.2) Pub Date : 2024-12-05 Xiaomin Su,Yazheng Yang,Yunhuan Gao,Juanjuan Wang,Yang Hao,Yuan Zhang,Rongcun Yang
Gut microbiota/metabolites not only participate in the food and energy metabolism but also contribute to the host immune response and homeostasis. The alternation of gut microbiota/metabolites has been widely related to intestinal and extra-intestinal disorders such as intestinal bowel diseases (IBDs). Bactericidal substances from gut epithelial cells can regulate the composition of gut microbiota
-
Omic characterizing and targeting gut dysbiosis in children with autism spectrum disorder: symptom alleviation through combined probiotic and medium-carbohydrate diet intervention - a pilot study. Gut Microbes (IF 12.2) Pub Date : 2024-12-04 Yalin Li,Weiwei Hu,Bing Lin,Teng Ma,Zhentian Zhang,Weiqian Hu,Rui Zhou,Lai-Yu Kwok,Zhihong Sun,Cuifeng Zhu,Heping Zhang
Autism spectrum disorder (ASD) currently lacks effective diagnostic and therapeutic approaches. Disruptions in the gut ecosystem have been observed in individuals with ASD, suggesting that targeting gut microbiota through probiotic and dietary supplementation may serve as a potential treatment strategy. This two-phase study aimed to characterize the fecal metagenome of children with ASD and investigate
-
Impaired postprandial GLP-2 response enhances endotoxemia, systemic inflammation, and kidney injury in metabolic dysfunction-associated steatohepatitis (MASH): effect of phospholipid curcumin meriva. Gut Microbes (IF 12.2) Pub Date : 2024-12-02 Giovanni Musso,Mella Alberto,Filippo Mariano,Maurizio Cassader,Franco De Michieli,Antonella Riva,Giovanna Petrangolini,Stefano Togni,Silvia Pinach,Roberto Gambino
We investigate the role of homeostatic mechanisms involved in acute, postprandial nutrient metabolism and nutrient-induced systemic inflammation in CKD presence and progression in Metabolic dysfunction-associated steatohepatitis (MASH). We assessed postprandial incretins (GLP-1 and GIP), intestinotropic hormone GLP-2, endotoxin LPS, Zonulin (a marker of intestinal permeability), hepatokines, adipokines
-
Defective Atg16l1 in intestinal epithelial cells links to altered fecal microbiota and metabolic shifts during pregnancy in mice. Gut Microbes (IF 12.2) Pub Date : 2024-12-02 Víctor A López-Agudelo,Maren Falk-Paulsen,Richa Bharti,Ateequr Rehman,Felix Sommer,Eike Matthias Wacker,David Ellinghaus,Anne Luzius,Laura Katharina Sievers,Manuel Liebeke,Arthur Kaser,Philip Rosenstiel
Throughout gestation, the female body undergoes a series of transformations, including profound alterations in intestinal microbial communities. Changes gradually increase toward the end of pregnancy and comprise reduced α-diversity of microbial communities and an increased propensity for energy harvest. Despite the importance of the intestinal microbiota for the pathophysiology of inflammatory bowel
-
Structure-dependent stimulation of gut bacteria by arabinoxylo-oligosaccharides (AXOS): a review. Gut Microbes (IF 12.2) Pub Date : 2024-11-29 Kai P Leschonski,Martin S Mortensen,Lea B S Hansen,Kristian B R M Krogh,Mirjam A Kabel,Martin F Laursen
Arabinoxylo-oligosaccharides (AXOS) are non-digestible dietary fibers that potentially confer a health benefit by stimulating beneficial bacteria in the gut. Still, a detailed overview of the diversity of gut bacteria and their specificity to utilize structurally different AXOS has not been provided to date and was aimed for in this study. Moreover, we assessed the genetic information of summarized
-
miMatch: a microbial metabolic background matching tool for mitigating host confounding in metagenomics research. Gut Microbes (IF 12.2) Pub Date : 2024-11-27 Lei Liu,Suqi Cao,Weili Lin,Zhigang Gao,Liu Yang,Lixin Zhu,Bin Yang,Guoqing Zhang,Ruixin Zhu,Dingfeng Wu
Metagenomic research faces a persistent challenge due to the low concordance across studies. While matching host confounders can mitigate the impact of individual differences, the influence of factors such as genetics, environment, and lifestyle habits on microbial profiles makes it exceptionally challenging to create fully matched cohorts. The microbial metabolic background, which modulates microbial
-
Unraveling the gut-skin axis in atopic dermatitis: exploiting insights for therapeutic strategies. Gut Microbes (IF 12.2) Pub Date : 2024-11-27 Marcela Rios-Carlos,Daniel Cervantes-García,Laura E Córdova-Dávalos,Luis G Bermúdez-Humarán,Eva Salinas
Gut microbiota exert functions of high importance in the intestine. Furthermore, there is increasing evidence for its role in immune regulation and maintenance of homeostasis in many physiological processes taking place in distant tissues. In particular, in this review, we explore the impact of metabolites produced by the gut microbiota on the development of atopic dermatitis (AD). Probiotics and prebiotics
-
IL-17 signaling protects against Helicobacter pylori-induced gastric cancer. Gut Microbes (IF 12.2) Pub Date : 2024-11-26 Lee C Brackman,Matthew S Jung,Emily H Green,Nikhita Joshi,Frank L Revetta,Mark S McClain,Nicholas O Markham,M Blanca Piazuelo,Holly M Scott Algood
Helicobacter pylori infection is the predominant risk factor for the development of gastric cancer. Risk is enhanced by specific H. pylori virulence factors, diet, and the inflammatory response. Chronic activation of T helper (Th) 1 and Th17 pathways contributes to prolonged inflammation; yet, higher expression of IL-17 receptor (IL-17RA) is a favorable prognostic marker for survival after gastric
-
Transcriptional profiling of zebrafish intestines identifies macrophages as host cells for human norovirus infection. Gut Microbes (IF 12.2) Pub Date : 2024-11-25 Emma Roux,Reegan J Willms,Jana Van Dycke,Álvaro Cortes Calabuig,Lore Van Espen,Geert Schoofs,Jelle Matthijnssens,Johan Neyts,Peter de Witte,Edan Foley,Joana Rocha-Pereira
Human noroviruses (HuNoVs) are a major cause of diarrheal disease, yet critical aspects of their biology, including cellular tropism, remain unclear. Although research has traditionally focused on the intestinal epithelium, the hypothesis that HuNoV infects macrophages has been recurrently discussed and is investigated here using a zebrafish larval model. Through single-cell RNA sequencing of dissected
-
Cerebrovascular damage caused by the gut microbe/host co-metabolite p-cresol sulfate is prevented by blockade of the EGF receptor. Gut Microbes (IF 12.2) Pub Date : 2024-11-24 Sita N Shah,Tobias B-A Knausenberger,Matthew G Pontifex,Emily Connell,Gwénaëlle Le Gall,Tom A J Hardy,David W Randall,Kieran McCafferty,Muhammad M Yaqoob,Egle Solito,Michael Müller,Andrew V Stachulski,Robert C Glen,David Vauzour,Lesley Hoyles,Simon McArthur
The gut microbiota-brain axis has been associated with the pathogenesis of numerous disorders, but the mechanism(s) underlying these links are generally poorly understood. Accumulating evidence indicates the involvement of gut microbe-derived metabolites. Circulating levels of the gut microbe/host co-metabolite p-cresol sulfate (pCS) correlate with cerebrovascular event risk in individuals with chronic
-
Probiotic significance of Lactobacillus strains: a comprehensive review on health impacts, research gaps, and future prospects. Gut Microbes (IF 12.2) Pub Date : 2024-11-24 Abdul Bari Shah,Aizhamal Baiseitova,Muhammad Zahoor,Ishaq Ahmad,Muhammad Ikram,Allah Bakhsh,Murad Ali Shah,Imdad Ali,Muhammad Idress,Riaz Ullah,Fahd A Nasr,Mohammed Al-Zharani
A rising corpus of research has shown the beneficial effects of probiotic Lactobacilli on human health, contributing to the growing popularity of these microorganisms in recent decades. The gastrointestinal and urinary tracts are home to these bacteria, which play a vital role in the microbial flora of both humans and animals. The Lactobacillus probiotic, i.e, Lactobacillus plantarum, Lactobacillus
-
Human milk oligosaccharides combine with Bifidobacterium longum to form the "golden shield" of the infant intestine: metabolic strategies, health effects, and mechanisms of action. Gut Microbes (IF 12.2) Pub Date : 2024-11-21 Shuo Yang,Junwu Cai,Qian Su,Qiaohui Li,Xiangchen Meng
Human milk oligosaccharides (HMOs) are the third most important nutrient in human milk and are the gold standard for infant nutrition. Due to the lack of an enzyme system capable of utilizing HMOs in the infant intestine, HMOs cannot be directly utilized. Instead, they function as natural prebiotics, participating in the establishment of the intestinal microbiota as a "bifidus factor." A crucial colonizer
-
Butyrate reduces epithelial barrier dysfunction induced by the foodborne mycotoxin deoxynivalenol in cell monolayers derived from pig jejunum organoids. Gut Microbes (IF 12.2) Pub Date : 2024-11-21 Julie Alberge,Eloïse Mussard,Carine Al-Ayoubi,Corinne Lencina,Christelle Marrauld,Laurent Cauquil,Caroline S Achard,Ivan Mateos,Imourana Alassane-Kpembi,Isabelle P Oswald,Laura Soler,Sylvie Combes,Martin Beaumont
The foodborne mycotoxin deoxynivalenol (DON) produced by Fusarium species threats animal and human health through disruption of the intestinal barrier. Targeting the gut microbiota and its products appears as a promising strategy to mitigate DON intestinal toxicity. In this study, we investigated whether the bacterial metabolite butyrate could alleviate epithelial barrier disruption induced by DON
-
B. vulgatus ameliorates high-fat diet-induced obesity through modulating intestinal serotonin synthesis and lipid absorption in mice. Gut Microbes (IF 12.2) Pub Date : 2024-11-21 Xinxin Wen,Xiaoyan Feng,Fang Xin,Rui An,Huanwei Huang,Liyuan Mao,Ping Liu,Jin Zhang,Haixia Huang,Xicheng Liu,Wei Wang
The consumption of high-fat diets (HFD) and an imbalance in gut microbiome are linked to obesity. However, the intricate connection between them and the underlying mechanisms involved in lipid digestion and absorption remain largely unclear. This study shows that after 12 weeks of HFD feeding, C57BL/6J mice exhibit two distinct metabolic phenotypes with significant differences in gut microbiota composition
-
Rotavirus rewires host cell metabolic pathways toward glutamine catabolism for effective virus infection. Gut Microbes (IF 12.2) Pub Date : 2024-11-20 Suvrotoa Mitra,Ratul Datta Chaudhuri,Rakesh Sarkar,Shreya Banerjee,Arpita Mukherjee,Ranjana Sharma,Animesh Gope,Kei Kitahara,Shin-Ichi Miyoshi,Mamta Chawla-Sarkar
Rotavirus (RV) accounts for 19.11% of global diarrheal deaths. Though GAVI assisted vaccine introduction has curtailed RV induced mortality, factors like RV strain diversity, differential infantile gut microbiome, malnutrition, interference from maternal antibodies and other administered vaccines, etc. often compromise vaccine efficacy. Herein emerges the need of antivirals which can be administered
-
More than just a number: the gut microbiota and brain function across the extremes of life. Gut Microbes (IF 12.2) Pub Date : 2024-11-20 Nathan D Nuzum,Clara Deady,Sarah Kittel-Schneider,John F Cryan,Siobhain M O'Mahony,Gerard Clarke
Understanding the interrelationship between the gut microbiota and host physiology, although still in its relative infancy, has taken important steps forward over the past decade. In the context of brain disorders including those characterized by neurodevelopmental and neurodegenerative changes there have been important advances. However, initially research involved correlational analyses, had limited
-
Microbiota-derived small molecule genotoxins: host interactions and ecological impact in the gut ecosystem. Gut Microbes (IF 12.2) Pub Date : 2024-11-18 Ellen L Zechner,Sabine Kienesberger
The human intestinal tract is densely colonized by a microbial community that is subject to intense competition. Bacteria in this complex habitat seek to outcompete their neighbors for nutrients and eliminate competitors with antibacterial toxins. Antagonism can be mediated by diverse effectors including toxic proteins and small molecule inhibitors that are released extracellularly or delivered by
-
Effects of gastric bypass bariatric surgery on gut microbiota in patients with morbid obesity. Gut Microbes (IF 12.2) Pub Date : 2024-11-17 Urja Amin,Dora Huang,Arun Dhir,Anya E Shindler,Ashley E Franks,Colleen J Thomas
The Western diet is associated with gastrointestinal dysbiosis, an active contributor to the pathophysiology of obesity and its comorbidities. Gastrointestinal dysbiosis is strongly linked to increased adiposity, low-grade inflammation, dyslipidaemia, and insulin resistance in individuals with morbid obesity. Bariatric bypass surgery remains the most effective treatment for achieving significant weight
-
Dysrupted microbial tryptophan metabolism associates with SARS-CoV-2 acute inflammatory responses and long COVID. Gut Microbes (IF 12.2) Pub Date : 2024-11-17 Lu Yao,Hannah Devotta,Junhui Li,Nonhlanhla Lunjani,Corinna Sadlier,Aonghus Lavelle,Werner C Albrich,Jens Walter,Paul W O'Toole,Liam O'Mahony
Protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and risk of long COVID has been associated with the depletion or over-abundance of specific taxa within the gut microbiome. However, the microbial mechanisms mediating these effects are not yet known. We hypothesized that altered microbial production of tryptophan and its downstream derivatives might contribute
-
Prebiotics in food and dietary supplements: a roadmap to EU health claims. Gut Microbes (IF 12.2) Pub Date : 2024-11-15 Kieran Tuohy,Elaine E Vaughan,Lucien F Harthoorn,Ellen E Blaak,Philip W J Burnet,Alessandro Busetti,Anirikh Chakrabarti,Nathalie Delzenne,Paul de Vos,Louise Dye,Damien Guillemet,Lesley A Houghton,Alwine F M Kardinaal,Cath Mersh,Kathy Musa-Veloso,Annegret Nielsen,Justyna Palasinska,Seppo Salminen,Gemma Walton,Naomi Venlet,Charlotte Hubermont,Philip C Calder
Numerous studies have established that prebiotic ingredients in foods and dietary supplements may play a role in supporting human health. Over the three decades that have passed since prebiotics were first defined as a concept, research has revealed a complex universe of prebiotic-induced changes to the human microbiota. There are strong indications of a direct link between these prebiotic-induced
-
Induction of intercrypt goblet cells upon bacterial infection: a promising therapeutic target to restore the mucosal barrier. Gut Microbes (IF 12.2) Pub Date : 2024-11-14 Renaud Léonard,Ewa Pasquereau-Kotula,Edwige Madec,Benjamin Marsac,Adriana Mihalache,Laurence du Merle,Jordan Denis,Corentin Spriet,Philippe Sansonetti,Shaynoor Dramsi,Catherine Robbe Masselot
Intestinal mucins play a crucial role in the mucosal barrier, serving as the body's initial defense against microorganisms. However, how the host regulates the secretion and glycosylation of these mucins in response to bacterial invasion remains unclear. Our study demonstrates that when exposed to Streptococcus gallolyticus (SGG), a gut pathobiont, the host mucosa promptly adjusts the behavior of specialized
-
Mechanisms of gut bacterial metabolism of dietary polyphenols into bioactive compounds. Gut Microbes (IF 12.2) Pub Date : 2024-11-14 Sara Alqudah,Jan Claesen
The fruits and vegetables we consume as part of our diet are rich in bioactive metabolites that can prevent and ameliorate cardiometabolic diseases, cancers, and neurological conditions. Polyphenols are a major metabolite family that has been intensively investigated in this context. However, for these compounds to exert their optimal bioactivity, they rely on the enzymatic capacity of an individual's
-
Lactic acid bacteria derived extracellular vesicles: emerging bioactive nanoparticles in modulating host health. Gut Microbes (IF 12.2) Pub Date : 2024-11-13 Mohan Li,Bingyong Mao,Xin Tang,Qiuxiang Zhang,Jianxin Zhao,Wei Chen,Shumao Cui
Lactic acid bacteria derived extracellular vesicles (LAB-EVs) are nano-sized and carry a variety of biological cargoes. LAB-EVs have proven to be potential mediators of intercellular communication, serving not only the parental bacteria but also the host cell in both physiology and pathology. LAB-EVs are therapeutically beneficial in various diseases through a cell-free strategy. Particularly, EVs
-
Differential contributions of the gut microbiota and metabolome to pathomechanisms in ulcerative colitis: an in vitro analysis. Gut Microbes (IF 12.2) Pub Date : 2024-11-13 Jonas Poppe,Leen Boesmans,Sara Vieira-Silva,Lise Deroover,Raul Tito,Doris Vandeputte,Greet Vandermeulen,Vicky De Preter,Jeroen Raes,Severine Vermeire,Gwen Falony,Kristin Verbeke
The gut microbiota has been implicated in onset and progression of ulcerative colitis (UC). Here, we assess potential causal involvement of the microbiota and -associated fecal water (FW) metabolome in altering key functional parameters of the colonic epithelium. Fecal samples were collected from N = 51 healthy controls (HC), N = 36 patients with active UC (UC-A), and N = 41 subjects in remission N = 41
-
Gut microbial metabolism of bile acids modifies the effect of Mediterranean diet interventions on cardiometabolic risk in a randomized controlled trial. Gut Microbes (IF 12.2) Pub Date : 2024-11-13 Peipei Gao,Ehud Rinott,Danyue Dong,Zhendong Mei,Fenglei Wang,Yuxi Liu,Omer Kamer,Anat Yaskolka Meir,Kieran M Tuohy,Matthias Blüher,Michael Stumvoll,Meir J Stampfer,Iris Shai,Dong D Wang
Bile acids (BAs) undergo extensive microbial metabolism in the gut and exert hormone-like functions on physiological processes underlying metabolic risk. However, the extent to which gut BA profiles predict cardiometabolic risk and explain individual responses to dietary interventions in humans is still unclear. In the DIRECT-PLUS Trial, we conducted a multi-omics analysis of 284 participants randomized
-
Stability in fecal metabolites amid a diverse gut microbiome composition: a one-month longitudinal study of variability in healthy individuals. Gut Microbes (IF 12.2) Pub Date : 2024-11-12 Matteo Sangermani,Indri Desiati,Solveig M Jørgensen,Jia V Li,Trygve Andreassen,Tone F Bathen,Guro F Giskeødegård
An extensive network of microbial-host interactions exists in the gut, making the gut microbiome a complex ecosystem to untangle. The microbial composition and the fecal metabolites are important readouts to investigate intricate microbiota-diet-host interplay. However, this ecosystem is dynamic, and it is of interest to understand the degree and timescale of changes occurring in the gut microbiota
-
Biosynthetic potential of the gut microbiome in longevous populations. Gut Microbes (IF 12.2) Pub Date : 2024-11-11 Sheng Liu,Zhao Zhang,Xudong Wang,Yan Ma,Hengfang Ruan,Xing Wu,Baoxia Li,Xiangyu Mou,Tao Chen,Zhengqi Lu,Wenjing Zhao
Gut microbiome plays a pivotal role in combating diseases and facilitating healthy aging, and natural products derived from biosynthetic gene clusters (BGCs) of the human microbiome exhibit significant biological activities. However, the natural products of the gut microbiome in long-lived populations remain poorly understood. Here, we integrated six cohorts of long-lived populations, encompassing
-
Immunogenicity and cross-protective efficacy induced by delayed attenuated Salmonella with regulated length of lipopolysaccharide in mice. Gut Microbes (IF 12.2) Pub Date : 2024-11-11 Xiaoping Bian,Qing Liu,Yaolin Chen,Wenjin Zhang,Mengru Li,Xiaofen Zhang,Liu Yang,Yonghong Liao,Qingke Kong
Non-typhoidal Salmonella enterica (NTS) is a major global foodborne pathogen that poses a major public health concern worldwide, and no vaccines are available for protecting against infection of multiple Salmonella serotypes, therefore, the development of Salmonella vaccines to provide broad protection is valuable. In this work, we aimed to regulate lipopolysaccharide (LPS) synthesis of live Salmonella
-
KRAS mutations promote the intratumoral colonization of enterotoxigenic bacteroides fragilis in colorectal cancer through the regulation of the miRNA3655/SURF6/IRF7/IFNβ axis. Gut Microbes (IF 12.2) Pub Date : 2024-11-10 Yizhen Chen,Shaolin Liu,Song Tan,Yuanyuan Zheng,Yifan Chen,Changshun Yang,Shengtao Lin,Yulong Mi,Weihua Li
KRAS mutations are associated with poor prognosis in colorectal cancer (CRC). Although the association between the gut microbiota and CRC has been extensively documented, it is unclear whether KRAS mutations can regulate the gut microbiota. Metagenomics has identified changes in the diversity of the gut microbiota in CRC due to KRAS mutations. Specifically, KRAS mutations positively correlate with
-
Reverse engineering the Gut-Brain Axis and microbiome-metabolomics for symbiotic/pathogenic balance in neurodegenerative diseases. Gut Microbes (IF 12.2) Pub Date : 2024-11-10 Muhammad Usman Munir,Syed Aoun Ali,Ka Hang Karen Chung,Aleksandr Kakinen,Ibrahim Javed,Thomas Paul Davis
Deciphering the molecular communications along the gut-brain axis can help in understanding the pathophysiology of neurodegenerative diseases and exploiting the gut microbiome for therapeutics. However, gut microbes and their metabolites have a multifaceted role in mediating both brain physiology and neurodegenerative pathology. There is a lack of understanding of how and when this role is tipped in
-
Intestinal flora: a potential pathogenesis mechanism and treatment strategy for type 1 diabetes mellitus. Gut Microbes (IF 12.2) Pub Date : 2024-11-09 Shengnan Huang,Fangfang Li,Chunhua Quan,Dan Jin
Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disease characterized by destruction of pancreatic β-cells, leading to insulin deficiency and hyperglycemia, and its incidence is increasing year by year. The pathogenesis of T1DM is complex, mainly including genetic and environmental factors. Intestinal flora is the largest microbial community in the human body and plays a very important role
-
Adhesin RadD: the secret weapon of Fusobacterium nucleatum. Gut Microbes (IF 12.2) Pub Date : 2024-11-09 Dingjiacheng Jia,Shujie Chen
Fusobacterium nucleatum can promote colorectal cancer (CRC) development through a variety of virulence proteins. Zhang et al. recently identified an adhesin RadD, for Fusobacterium nucleatum adhesion to CRC. Targeting the interaction between RadD and CD147 will provide a new strategy for CRC treatment. This Commentary and View not only summarizes the research highlights but also discusses the possibility
-
Impact of an intranasal L-DBF vaccine on the gut microbiota in young and elderly mice. Gut Microbes (IF 12.2) Pub Date : 2024-11-09 Ti Lu,Aaron C Ericsson,Zackary K Dietz,Alexa K Cato,Lyndon M Coghill,William D Picking,Wendy L Picking
Shigella spp. cause bacillary dysentery (shigellosis) with high morbidity and mortality in low- and middle-income countries. Infection occurs through the fecal-oral route and can be devastating for vulnerable populations, including infants and the elderly. These bacteria invade host cells using a type III secretion system (T3SS). No licensed vaccine yet exists for shigellosis, but we have generated
-
Colonization resistance: the role of gut microbiota in preventing Salmonella invasion and infection. Gut Microbes (IF 12.2) Pub Date : 2024-11-08 Lei Deng,Shaohui Wang
The human gastrointestinal tract is colonized by a complex microbial ecosystem, the gut microbiota, which is pivotal in maintaining host health and mediating resistance to diseases. This review delineates colonization resistance (CR), a critical defensive mechanism employed by the gut microbiota to safeguard against pathogenic bacterial invasions, notably by Salmonella. We detail the mechanisms through
-
PPARα exacerbates Salmonella Typhimurium infection by modulating the immunometabolism and macrophage polarization. Gut Microbes (IF 12.2) Pub Date : 2024-11-07 Jessica R Taddeo,Naomi Wilson,Anita Kowal,Joris Beld,Klein-Szanto Andres,Çagla Tükel,Vincent C Tam
Salmonella enterica serovar Typhimurium (STm) is a causative pathogen for robust inflammatory gastrointestinal disease and can lead to systemic infection. Eicosanoids, bioactive lipid mediators, play a crucial role in modulating both the induction and resolution of inflammatory responses during an infection. A subset of eicosanoids activates PPARs, nuclear receptor/transcription factors that regulate
-
The effects of gut microbiota on appetite regulation and the underlying mechanisms Gut Microbes (IF 12.2) Pub Date : 2024-11-06 Miao Yu, Bing Yu, Daiwen Chen
Appetite, a crucial aspect regulated by both the central nervous system and peripheral hormones, is influenced by the composition and dynamics of the intestinal microbiota, as evidenced by recent r...
-
Transfer of microbiota from lean donors in combination with prebiotics prevents excessive weight gain and improves gut-brain vagal signaling in obese rats Gut Microbes (IF 12.2) Pub Date : 2024-11-01 Dulce M. Minaya, Jiyoung S Kim, Rebecca Kirkland, Jillian Allen, Sitara Cullinan, Neil Maclang, Guillaume de Lartigue, Claire de La Serre
Gastrointestinal (GI) microbiota plays an active role in regulating the host’s immune system and metabolism, as well as certain pathophysiological processes. Diet is the main factor modulating GI m...
-
Giardia antagonizes beneficial functions of indigenous and therapeutic intestinal bacteria during protein deficiency. Gut Microbes (IF 12.2) Pub Date : 2024-11-05 Aadra P Bhatt,Jason W Arnold,Muyiwa Awoniyi,Shan Sun,Verônica Feijoli Santiago,Deniz Coskuner,Pedro Henrique Quintela,Kenneth Walsh,Jamie Xiao,Renay Ngobeni-Nyambi,Brenna Hansen,Ajay S Gulati,Ian M Carroll,M Andrea Azcarate-Peril,Anthony A Fodor,Jonathan Swann,Luther A Bartelt
Undernutrition in children commonly disrupts the structure and function of the small intestinal microbial community, leading to enteropathies, compromised metabolic health, and impaired growth and development. The mechanisms by which diet and microbes mediate the balance between commensal and pathogenic intestinal flora remain elusive. In a murine model of undernutrition, we investigated the direct
-
Faecal (or intestinal) microbiota transplant: a tool for repairing the gut microbiome. Gut Microbes (IF 12.2) Pub Date : 2024-11-05 Rohma Ghani,Despoina Chrysostomou,Lauren A Roberts,Madhumitha Pandiaraja,Julian R Marchesi,Benjamin H Mullish
Faecal/intestinal microbiota transplant (FMT/IMT) is an efficacious treatment option for recurrent Clostridioides difficile infection, which has prompted substantial interest in FMT's potential role in the management of a much broader range of diseases associated with the gut microbiome. Despite its promise, the success rates of FMT in these other settings have been variable. This review critically
-
A pathophysiologic framework for the overlap of disorders of gut-brain interaction and the role of the gut microbiome Gut Microbes (IF 12.2) Pub Date : 2024-10-31 Ayesha Shah, Yeong Yeh Lee, Hidekazu Suzuki, Joash Tan-Loh, Kewin Tien Ho Siah, Kok-Ann Gwee, Thomas Fairlie, Nicholas J. Talley, Uday C Ghoshal, Yen-Po Wang, Yong Sung Kim, Gerald Holtmann
The International Rome Committee defines Disorders of Gut-Brain Interactions (DGBI) based upon distinct combinations of chronic and/or recurrent unexplained gastrointestinal symptoms. Yet patients ...
-
Symbiotic probiotic communities with multiple targets successfully combat obesity in high-fat-diet-fed mice Gut Microbes (IF 12.2) Pub Date : 2024-11-03 Dingming Guo, Yun Deng, Qianqian Yang, Min Li, Xiangfeng Wang, Xuchun Wan, Junqing He, Ying Xu, Wenxin Huang, Guohua Lin, Ya Xu, Yi Sun, Ruilin Zhang, Wei-Hua Chen, Zhi Liu
Probiotics hold great potential for treating metabolic diseases such as obesity. Given the complex and multifactorial nature of these diseases, research on probiotic combination with multiple targe...
-
Oral administration of Lactobacillus casei DG® after ileostomy closure in restorative proctocolectomy: a randomized placebo-controlled trial (microbiota and immune microenvironment in pouchitis -MEP1) Gut Microbes (IF 12.2) Pub Date : 2024-11-01 Imerio Angriman, Melania Scarpa, Edoardo Savarino, Ilaria Patuzzi, Alessandra Rigo, Andromachi Kotsafti, Astghik Stepanyan, Elisa Sciuto, Francesco Celotto, Silvia Negro, Antonino Caruso, Cesare Ruffolo, Romeo Bardini, Salvatore Pucciarelli, Brigida Barberio, Gaya Spolverato, Fabiana Zingone, Renata D’Incà, Ignazio Castagliuolo, Marco Scarpa
Pouchitis is an idiopathic inflammatory disease that may occur in ileal pouches, and it can lead to ileal pouch failure. This was a single-center, randomized, double-blinded, placebo-controlled tri...
-
The case for microbial intervention at weaning Gut Microbes (IF 12.2) Pub Date : 2024-10-28 Julia N. Flores, Jean-Bernard Lubin, Michael A. Silverman
Weaning, the transition from a milk-based diet to solid food, coincides with the most significant shift in gut microbiome composition in the lifetime of most mammals. Notably, this period also mark...
-
A gut feeling of statin Gut Microbes (IF 12.2) Pub Date : 2024-10-29 Jianqing She, Lizhe Sun, Yue Yu, Heze Fan, Xia Li, Xinyu Zhang, Xiaozhen Zhuo, Manyun Guo, Junhui Liu, Peining Liu, Gulinigaer Tuerhongjiang, Bin Du, Hongbing Li, Jun Yu, Zuyi Yuan, Yue Wu
Statins, known as HMG-CoA reductase inhibitors, are widely utilized to reduce blood cholesterol levels and possess pleiotropic effects, including the influence on inflammation and macrophage prolif...
-
Exercise-changed gut mycobiome as a potential contributor to metabolic benefits in diabetes prevention: an integrative multi-omics study Gut Microbes (IF 12.2) Pub Date : 2024-10-29 Yao Wang, Jiarui Chen, Yueqiong Ni, Yan Liu, Xiang Gao, Michael Andrew Tse, Gianni Panagiotou, Aimin Xu
The importance of gut microbes in mediating the benefits of lifestyle intervention is increasingly recognized. However, compared to the bacterial microbiome, the role of intestinal fungi in exercis...
-
Lactobacillaceae differentially impact butyrate-producing gut microbiota to drive CNS autoimmunity Gut Microbes (IF 12.2) Pub Date : 2024-10-27 Theresa L. Montgomery, Lucinda C. Toppen, Korin Eckstrom, Eamonn R. Heney, Josephine J. Kennedy, Matthew J. Scarborough, Dimitry N. Krementsov
Short-chain fatty acids (SCFAs), produced by the gut microbiota, are thought to exert an anti-inflammatory effect on the host immune system. The levels of SCFAs and abundance of the microbiota that...